Solid Biosciences Inc. Earnings Per Share (Basic)
Solid Biosciences Inc. (SLDB) reported Earnings Per Share (Basic) of -$0.38 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- Solid Biosciences Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.38.
- Solid Biosciences Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.52.
- Solid Biosciences Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.48.
- Solid Biosciences Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.42.
- Solid Biosciences Inc. earnings per share, basic for fiscal 2025 was -$1.99.
- Solid Biosciences Inc. earnings per share, basic for fiscal 2024 was -$3.06.
- Solid Biosciences Inc. earnings per share, basic for fiscal 2023 was -$4.83.
- Solid Biosciences Inc. earnings per share, basic for fiscal 2022 was -$10.10.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.38 10-Q · filed 2026-08-06 | -$0.88 10-Q · filed 2026-08-06 | ||||
| 2026-03-31 | -$0.52 10-Q · filed 2026-05-12 | |||||
| 2025-12-31 | -$1.99 10-K · filed 2026-03-19 | |||||
| 2025-09-30 | -$0.48 10-Q · filed 2025-11-03 | -$1.46 10-Q · filed 2025-11-03 | ||||
| 2025-06-30 | -$0.42 10-Q · filed 2026-08-06 | -$0.98 10-Q · filed 2026-08-06 | ||||
| 2025-03-31 | -$0.59 10-Q · filed 2026-05-12 | |||||
| 2024-12-31 | -$3.06 10-K · filed 2026-03-19 | |||||
| 2024-09-30 | -$0.79 10-Q · filed 2025-11-03 | -$2.04 10-Q · filed 2025-11-03 | ||||
| 2024-06-30 | -$0.61 10-Q · filed 2025-08-12 | -$1.25 10-Q · filed 2025-08-12 | ||||
| 2024-03-31 | -$0.64 10-Q · filed 2025-05-15 | |||||
| 2023-12-31 | -$4.83 10-K · filed 2025-03-06 | |||||
| 2023-09-30 | -$1.05 10-Q · filed 2024-11-06 | -$2.30 derived: net income ÷ weighted average shares · filed 2024-11-06 | -$3.83 10-Q · filed 2024-11-06 | |||
| 2023-06-30 | -$1.25 10-Q · filed 2024-08-13 | -$2.79 10-Q · filed 2024-08-13 | ||||
| 2023-03-31 | -$1.54 10-Q · filed 2024-05-15 | |||||
| 2022-12-31 | -$10.10 10-K · filed 2024-03-13 | |||||
| 2022-09-30 | -$2.71 10-Q · filed 2023-11-08 | -$6.04 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$9.42 10-Q · filed 2023-11-08 | |||
| 2022-06-30 | -$3.33 10-Q · filed 2023-08-14 | -$0.22 10-Q · filed 2022-08-11 | -$6.71 10-Q · filed 2023-08-14 | -$0.45 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | -$3.37 10-Q · filed 2023-05-11 | |||||
| 2021-12-31 | -$10.14 10-K · filed 2024-03-13 | |||||
| 2021-09-30 | -$2.40 10-Q · filed 2022-11-10 | -$0.61 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$7.68 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | -$0.17 10-Q · filed 2022-08-11 | -$0.35 10-Q · filed 2022-08-11 | ||||
| 2020-12-31 | -$25.50 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |